ArticleCancer medicine2018

Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib-resistant lung adenocarcinoma cells.

Jie Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.